TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/23/25 16:06 | 10/21/25 | SMMT | Summit Therapeutics Inc. | Health | Drug | Pharmaceutical Preparations | Zanganeh Mahkam | FL | DOT | Co-CEO | P | 500 | 18.74 | 0 | 27 | 0 | 606,106 | I | |||||||||||||||
9/11/25 19:36 | 9/10/25 | SMMT | Summit Therapeutics Inc. | Health | Drug | Pharmaceutical Preparations | Zanganeh Mahkam | FL | DOT | Co-CEO | P.m | 5,985 | 17.69 | 0 | 338 | 0 | 591,832 | I | |||||||||||||||
3/27/24 20:28 | 3/27/24 | SMMT | Summit Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Zanganeh Mahkam | CA | DO | CEO | P.m | 411 | 3.73 | 0 | 110 | 0 | 25,495 | M | ||||||||||||||
12/13/23 17:11 | 12/12/23 | SMMT | Summit Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Zanganeh Mahkam | CA | DO | CEO | P.d | 10 | 2.07 | 0 | 5 | 0 | 25,384 | M | ||||||||||||||
3/13/23 18:27 | 3/8/23 | SMMT | Summit Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Zanganeh Mahkam | CA | DO | Co-CEO,P | P.a | 24,703 | 1.05 | 0 | 23,527 | 215 | 34,458 | I | ||||||||||||||
3/8/23 21:31 | 3/8/23 | SMMT | Summit Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Zanganeh Mahkam | CA | DO | Co-CEO | P | 24,703 | 1.05 | 0 | 23,527 | 215 | 34,458 | M |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |